Share |

Content about United Kingdom

August 10, 2015

Germantown, Md-based IntrexonCorporation (NYSE: XON) continues to fuel its growth by buying viable biotechnology companies. This time the bioindustrial focused company has entered an agreement to purchase Oxitec, a spin off from Oxford University in the United Kingdom, founded in 2002.

Oxitec uses genetic engineering to control insect pests and protect crops. The technonolgy is particulary focused on control the mosquitoes and the diseases they spread.

July 29, 2015

Treatment for chronic hepatitis B (CHB) has improved significantly in the last 10 years but despite those improvements  360 million people or 5 percent of the world’s population remain chronically infected by the Hepatitis B virus (HBV). That's according to Gaithersburg, Md-based Vaxin Inc, the company recently announced that it has initiated Phase 1 clinical stage trial to test a vaccine treatment for HepTcell, its' immunotherapeutic compound to treat people who are chronically infected with HBV.

March 21, 2014

Washington, D.C.-based Vanda Pharmaceuticals Inc (NASDAQ:VNDA), has launched a couple of drugs and even recently put into place a television ad campaign. The company is now in need of extra space and will expand into an additional 8,600 square feet at its D.C. headquarters located at 2200 Pennsylvania Avenue.

Vanda will pay the landlord, Square 54 Office Owner LLC, and additional $381,000 for a 12 year and one month term lease beginning on September 1, 2014, although Vanda will get a nine month grace period.

March 13, 2014

In late 2012 Sucampo Pharmaceuticals (NASDAQ: SCMP) received approval from the Food and Drug Administration (FDA)  to expand upon its gastrointestinal drug -- AMITIZA -- to treat people with opioid-induced constipation (OIC) in the United States.

With increasing competition from other biotechnology companies, that approval is keeping the Bethesda-based drug developer ahead of them and profitable, with a net income posted in 3 out of the last 4 quarters of 2013, including the most recent fourth quarter.

March 13, 2014

Germantown, Maryland-based Intrexon Corporation (NYSE:XON) stock was recently upgraded by EVA Dimensions last week but that doesn’t explain yesterdays price surge of more than 10 percent for the company.

Intrexon was the third most price-trending stock on Google Finance yesterday, the stock price of the company increased more than 11.46 percent (+ $3.14) to close at $30.55 per share.

A few reasons that could have driven Intrexon’s stock price higher,

March 13, 2014

In late 2012 Sucampo Pharmaceuticals (NASDAQ: SCMP) received approval from the Food and Drug Administration (FDA)  to expand upon its gastrointestinal drug -- AMITIZA -- to treat people with opioid-induced constipation (OIC) in the United States.

With increasing competition from other biotechnology companies, that approval is keeping the Bethesda-based drug developer ahead of them and profitable, with a net income posted in 3 out of the last 4 quarters of 2013, including the most recent fourth quarter.

October 26, 2011

Bethesda-based Lockheed Martin's (NYSE: LMT), Lockheed Martin UK subsidiary was selected by the United Kingdom Ministry of Defence to lead the upgrade of the British Army's Warrior Armoured Fighting Vehicle.

The defense giant will get 642 million pounds (approximately $1 billion) as part of a larger 1 billion pounds (approximately $1.6 billion) contract.

September 12, 2011

McLean-Based Science Applications International Corporation (SAIC) (NYSE: SAI) said former Rockville-based BAE Systems Inc Senior Vice President, Corporate Communications, Lucy Reilly Fitch will become their own Senior VP of Corporate Communications.

August 4, 2011

Bethesda-based First Potomac Realty Trust (NYSE: FPO) has formed a joint venture with Perseus Realty of D.C. to develop the Greyhound Bus Terminal site at 1005 First Street, NE, Washington, D.C.

The site in the NoMa corridor (North of Massachusetts Avenue) was purchased for $46.75 Million with the intent of redeveloping it into a 712,000 square foot Class-A, LEED certified office building.

July 12, 2011

General Dynamic's Electric Boat division based in Groton, Connecticut received a modified contract for continued work on the  U.S. Ohio replacement submarine

and successor to the United Kingdom's ballistic-missile submarine.

The original contract, initiated in December 2008 was valued at $76 million.

The overall contract for U.S. Navy and U.K. Royal Navy next generation submarines could be as high as $651 Million.

General Dynamic's corporate headquarters is based in Fairfax county.